
|Videos|August 3, 2017
What is the Goal of Treat-to-Target in Patients with Rheumatoid Arthritis?
What is the importance and prevalence of treat-to-target?
Advertisement
Marcus H. Snow, MD, from University of Nebraska Medical Center, speaks about the importance of treat-to-target and its goal of disease remission in patients with rheumatoid arthritis. Dr. Snow believes that most physicians already practice an informal treat-to-target therapy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
3
Long-Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM
4
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
5

















































































































































































































